Sprout Reviews
Save $200 on your first month
Last updated: Sep 14, 2026
Medically reviewed by Francheska Capistrano, RMT, MPH · · How we review
Medically reviewed by Francheska Capistrano, RMT, MPH · Medical Content Reviewer
Medically reviewed on Reviewed · Written by Treatments Hub Research Team
We may earn a commission from links on this page - it never affects our rankings (how we stay objective).
The bottom line
Sprout earns its place as a mid-market pick: semaglutide from $99/month and tirzepatide from $149/month on the 12-month plan ($149 and $199 month to month) with prescriptions shipped within 2 days and - unusually for this tier - a brand-name Wegovy shelf. The honest caveat: month to month the value tier undercuts it by $50-$90/month on the same molecules.
Pick Sprout for the speed, the personalization and the brand-name option; pick welludr or embody if the lowest compounded price is all that matters.
Sprout products & prices
Published prices with their conditions - the whole card links to the provider.
Sprout is a telehealth GLP-1 program with a straightforward pitch: personalized treatment plans built around your health goals, prescriptions shipped within 2 days of approval, and a menu that covers both lanes - compounded semaglutide starting at $99/month and compounded tirzepatide at $149/month on the 12-month plan ($149 and $199 month to month), with brand-name Wegovy available from $1,799/month for anyone set on the branded pen. Its month-to-month pricing sits mid-market: above the $41-$99 value tier, below TrimRx and SHED - and its 12-month plan brings semaglutide down to $99 - the fair way to read Sprout is speed and personalization at a middle price.
Key Features
- Compounded semaglutide from $99/mo (12-month plan; $149/mo month to month)
- Compounded tirzepatide from $149/mo (12-month plan; $199/mo month to month)
- Brand-name Wegovy available (from $1,799/mo)
- Prescriptions shipped within 2 days
Treatment Options
- Compounded semaglutide (GLP-1) injection
- Compounded tirzepatide (GLP-1 + GIP) injection
- Brand-name Wegovy (semaglutide) pen
- Personalized, provider-guided treatment plans
Pricing
GLP-1
WeeklyCompounded Semaglutide
- One simple injection per week
- 12-month plan, $1,188 billed upfront; $149/month with no commitment
GLP-1 + GIP
WeeklyCompounded Tirzepatide
- One simple injection per week
- 12-month plan, $1,788 billed upfront; $199/month with no commitment
Wegovy
Brand-name semaglutide pen
- FDA-approved brand-name pen
- Starting price
Sprout prices compounded semaglutide from $99/month and compounded tirzepatide from $149/month on its 12-month plan ($1,188 and $1,788 billed upfront for a 52-week supply), with 6-month ($110 / $160), 3-month ($125 / $180) and monthly no-commitment ($149 / $199) plans - the same price at any dose, with no membership fee. Plans renew until cancelled, and you can cancel any time before the next refill.
Brand-name Wegovy is from $1,799/month for those who want the branded pen. That positions Sprout mid-market month to month: the value tier (welludr $41, embody $49, Medvi's $99 promo) is cheaper for compounded medication, but few mid-tier rivals also stock a brand-name option.
Confirm current plan terms and the first-month offer on Sprout's site before checkout.
What we verified
Checked September 2026
Every line below was checked against Sprout's own published pricing and plan information - not copied from other review sites. When we can't verify something, we leave it out rather than guess.
- Semaglutide price
- From $99/month on the 12-month plan; $149/month with no commitment
- Tirzepatide price
- From $149/month on the 12-month plan; $199/month with no commitment
- Brand-name option
- Wegovy $1,799/month
Pros
- Fast fulfillment - prescriptions shipped within 2 days
- Both compounded lanes plus a brand-name Wegovy option
- Personalized plans built around your goals
Cons
- Mid-market month-to-month pricing: $149 semaglutide vs $41-$99 at the value tier
- The lowest rates need the 12-month plan, billed upfront, and plans renew until cancelled
Who It's Best For
- People who want their prescription shipped fast (within 2 days)
- Anyone who wants a brand-name Wegovy option alongside compounded plans
- Those who value personalized plans over the lowest sticker price
Final Verdict
Sprout earns its place as a mid-market pick: semaglutide from $99/month and tirzepatide from $149/month on the 12-month plan ($149 and $199 month to month) with prescriptions shipped within 2 days and - unusually for this tier - a brand-name Wegovy shelf. The honest caveat: month to month the value tier undercuts it by $50-$90/month on the same molecules.
Pick Sprout for the speed, the personalization and the brand-name option; pick welludr or embody if the lowest compounded price is all that matters.
Sprout Review: FAQs
Is Sprout legit?
Sprout is a telehealth GLP-1 program with a straightforward pitch: personalized treatment plans built around your health goals, prescriptions shipped within 2 days of approval, and a menu that covers both lanes - compounded semaglutide starting at $99/month and compounded tirzepatide at $149/month on the 12-month plan ($149 and $199 month to month), with brand-name Wegovy available from $1,799/month for anyone set on the branded pen. Its month-to-month pricing sits mid-market: above the $41-$99 value tier, below TrimRx and SHED - and its 12-month plan brings semaglutide down to $99 - the fair way to read Sprout is speed and personalization at a middle price.
How much does Sprout cost?
Sprout prices compounded semaglutide from $99/month and compounded tirzepatide from $149/month on its 12-month plan ($1,188 and $1,788 billed upfront for a 52-week supply), with 6-month ($110 / $160), 3-month ($125 / $180) and monthly no-commitment ($149 / $199) plans - the same price at any dose, with no membership fee. Plans renew until cancelled, and you can cancel any time before the next refill. Brand-name Wegovy is from $1,799/month for those who want the branded pen. That positions Sprout mid-market month to month: the value tier (welludr $41, embody $49, Medvi's $99 promo) is cheaper for compounded medication, but few mid-tier rivals also stock a brand-name option. Confirm current plan terms and the first-month offer on Sprout's site before checkout.
What treatments does Sprout offer?
Sprout offers Compounded semaglutide (GLP-1) injection, Compounded tirzepatide (GLP-1 + GIP) injection, Brand-name Wegovy (semaglutide) pen, Personalized, provider-guided treatment plans.
Who is Sprout best for?
Sprout is best for People who want their prescription shipped fast (within 2 days); Anyone who wants a brand-name Wegovy option alongside compounded plans; Those who value personalized plans over the lowest sticker price.
Is Sprout worth it?
Sprout earns its place as a mid-market pick: semaglutide from $99/month and tirzepatide from $149/month on the 12-month plan ($149 and $199 month to month) with prescriptions shipped within 2 days and - unusually for this tier - a brand-name Wegovy shelf. The honest caveat: month to month the value tier undercuts it by $50-$90/month on the same molecules. Pick Sprout for the speed, the personalization and the brand-name option; pick welludr or embody if the lowest compounded price is all that matters.
How fast does Sprout ship?
Sprout ships prescriptions within 2 days of approval - among the faster fulfillment windows in our ranking. The process starts with an online intake reviewed by a licensed provider.
Does Sprout offer brand-name medication?
Yes - alongside compounded semaglutide (from $99/month on the 12-month plan) and compounded tirzepatide (from $149/month), Sprout lists brand-name Wegovy from $1,799/month, making it one of the few mid-tier providers with a branded option on the shelf.
How much does Sprout cost per month?
Compounded semaglutide starts at $99/month and compounded tirzepatide at $149/month on the 12-month plan ($1,188 and $1,788 billed upfront). The 6-month plan is $110 and $160, the 3-month plan $125 and $180 and the monthly plan with no commitment $149 and $199. Every plan is the same price at any dose, with no membership fee. Brand-name Wegovy starts at $1,799/month. Confirm current plan terms and the first-month offer on Sprout's site.
Not sure if Sprout is right for you?
Take our free quiz and get a personalized provider recommendation.
Find Your MatchRelated
Head-to-head
Three-way comparisons
Guides
More on Sprout
The questions people ask before signing up - answered in depth.
Sources & methodology
We built this review of Sprout from the provider'sown published pricing, plans and policies, cross-checked against regulatory and peer-reviewed medical references, and read alongside real customer feedback. Prices and plan details were verified against the provider's published information; we do not take providers' word for their own claims without checking.
Provider information
Pricing, plans, shipping and policies, checked against each provider's own site.
- Sprout - pricing, plans & policies as published on its own site
Provider data checked September 2026
Customer & community feedback
Third-party signals shown on this page and in our full reviews: public Reddit discussions and independent YouTube reviews. We report what these sources say - we never fold them into our own scores.
Medical & regulatory references
- 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
- 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
- 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
- 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
- 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
- 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
- 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)
Last reviewed September 2026. We revisit comparisons when providers change their pricing or policies. This page is information only and is not medical advice - always consult a licensed clinician before starting treatment.
Medical disclaimer
This page is general information about GLP-1 weight-loss medications such as semaglutide and tirzepatide, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.
Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumours seen in rodents and are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, nor for use in pregnancy. Compounded versions sold by telehealth providers are prepared by state-licensed pharmacies and are not FDA-approved products. Where a review or post on this page mentions weight lost, that is one person's result and is not typical; results vary widely.
Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.
Sources & medical references
Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.
- 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
- 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
- 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
- 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
- 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
- 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
- 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)



